University of Illinois
Ananda Mohan Chakrabarty is a distinguished University Professor at the University of Illinois, College of Medicine, Department of Microbiology and Immunology at Chicago. His research interest involves development of promiscuous bacterial protein/peptide drugs with anticancer, anti-viral and anti-parasitic activities. He is the Co-Founder of two startup companies, CDG Therapeutics Inc., in Chicago and Amrita Therapeutics in India.
My project involves the development of bacterial proteins/peptides as anticancer agents.